Viewing Study NCT05902494


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2025-12-26 @ 2:36 AM
Study NCT ID: NCT05902494
Status: COMPLETED
Last Update Posted: 2025-07-20
First Post: 2023-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module